QLT Asks FDA To Remove Blood Screening Requirement For Acne Treatment Aczone
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm hopes results of Phase IV study convince FDA to approve a more marketable label for the topical acne treatment.